This site requires javascript. Please turn that on in your browser\'s preferences. How?

Axis Neuromonitoring Axis Neuromonitoring

AXIS Neuromonitoring delivers:

  • High Quality Neuromonitoring
  • Cutting-Edge Technology and Techniques
  • Caring and Professional Staff
  • Risk Management Advantages
  • Best Practices in IONM
  • Attractive Pricing Packages
  • Certified IT Security Specialists
  • Patient Care Advocacy Specialists
  • Data Metrics Collection for QA
  • Highly skilled billing department working to solve payor issues

High Quality Neuromonitoring

For each surgery, we provide both an onsite technologist and an offsite telemonitoring physician so your surgeon can get instant feedback.

Both of these professionals work together to ensure that neural pathways are monitored effectively throughout a procedure. Two sets of eyes on the neural data help ensure that your surgeon receives real time feedback if response time or intensities change, allowing the surgeon to make any necessary corrections and maintain integrity of the nerves. This allows your entire staff to have more comfort and control during the procedure.

Cutting-Edge Technology

We work with top-of-the-line manufacturers and software companies to equip our technologists, and thus your surgeons, with the most advanced neuromonitoring systems available.

Risk Management

Intraoperative monitoring services can significantly reduce postoperative complications. We are dedicated to our patients, which means we are dedicated to our hospitals and surgeons. We understand that all surgical procedures carry risk. However, we aim to not only reduce that risk, but to prevent additional surgeries, impairment, and frivolous litigation.

Best Practices

AXIS Neuromonitoring is constantly working to improve our service to you and the patient. Establishing Best Practices in IONM ensures our commitment in providing high-quality healthcare.

Our clinical guidelines are amongst those of the highest level in the industry. All technologists are members of ASET and are either board certified or pursuant in their CNIM or R.EP T certification from ABRET.

Our staff training program consists of a minimum of 150 supervised cases during which the technologist is required to attend one of the recognized training courses. They also participate in continuing education to keep up to date with the latest technologies and procedures.

AXIS Neuromonitoring complies with all rules and regulations set by local, state and federal agencies. We also follow the standards demanded by Joint Commission, AORN, and professional organizations in our field such as ABRET, ASET, and  ASNM.

Procedures

For a list of procedures where patients can benefit from neuromonitoring, please visit the Our Procedures page.

Latest News

03.30.20
Surgical approach linked to risk in hip replacement

The researchers say that the anterior approach to hip arthroplasty is slightly more risky than the posterior or lateral approaches. "The small but statistically significant increase in the risk of major surgical complications associated with the anterior approach may help inform decisions for total hip arthroplasty," write Daniel Pincus, MD, PhD, of the Sunnybrook Health Sciences Center in Toronto, Canada, and his colleagues.

03.27.20
Minimally Invasive Artificial Disc Replacement Shows “Significantly Better Results” Compared to Traditional Procedures (Source: Minimally Invasive Neurosurgery of Texas)

Dr. Scott Kutz, an expert in the field of cervical spine surgery, has published a new article that discusses how minimally invasive spine surgery has shown “significantly better results” in terms of risks and recovery period than traditional open spine surgery.

03.23.20
NorthShore neurosurgeon first in Illinois to offer new targeted therapy for brain tumors

NorthShore University HealthSystem (NorthShore) neurosurgeon, Julian Bailes, MD, is the first in Illinois to begin offering GammaTile® Therapy, a new approach to treating malignant brain tumors. The FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) is designed to delay tumor regrowth for patients with high grade gliomas, meningiomas and brain metastases. The first patient in the state was treated by Dr. Bailes who is chairman of the department of neurosurgery and co-director of the NorthShore Neurological Institute. Neuro-oncologist Ryan Merrell, MD, will also be participating in this new surgical therapy at NorthShore.

All News